
Assembly Biosciences Inc
NASDAQ:ASMB

Intrinsic Value
The intrinsic value of one
ASMB
stock under the Base Case scenario is
12.6
USD.
Compared to the current market price of 17.08 USD,
Assembly Biosciences Inc
is
Overvalued by 26%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Assembly Biosciences Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Assembly Biosciences Inc
Balance Sheet Decomposition
Assembly Biosciences Inc
Current Assets | 95.5m |
Cash & Short-Term Investments | 91m |
Other Current Assets | 4.5m |
Non-Current Assets | 3.5m |
PP&E | 3.2m |
Other Non-Current Assets | 312k |
Free Cash Flow Analysis
Assembly Biosciences Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Assembly Biosciences Inc
Revenue
|
32.2m
USD
|
Operating Expenses
|
-76.8m
USD
|
Operating Income
|
-44.6m
USD
|
Other Expenses
|
4.7m
USD
|
Net Income
|
-39.9m
USD
|
ASMB Profitability Score
Profitability Due Diligence
Assembly Biosciences Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

Score
Assembly Biosciences Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
ASMB Solvency Score
Solvency Due Diligence
Assembly Biosciences Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Score
Assembly Biosciences Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ASMB Price Targets Summary
Assembly Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
ASMB
is 32.3 USD
with a low forecast of 29.29 USD and a high forecast of 36.75 USD.
Dividends
Current shareholder yield for ASMB is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ASMB
stock under the Base Case scenario is
12.6
USD.
Compared to the current market price of 17.08 USD,
Assembly Biosciences Inc
is
Overvalued by 26%.